AR020927A1 - Composicion farmaceutica que contiene fragmentos de adn codificador de una proteina antigenica dotada de efecto antitumoral - Google Patents

Composicion farmaceutica que contiene fragmentos de adn codificador de una proteina antigenica dotada de efecto antitumoral

Info

Publication number
AR020927A1
AR020927A1 ARP990105316A ARP990105316A AR020927A1 AR 020927 A1 AR020927 A1 AR 020927A1 AR P990105316 A ARP990105316 A AR P990105316A AR P990105316 A ARP990105316 A AR P990105316A AR 020927 A1 AR020927 A1 AR 020927A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical composition
composition containing
dna fragments
antigen protein
coding dna
Prior art date
Application number
ARP990105316A
Other languages
English (en)
Spanish (es)
Original Assignee
Menarini Ricerche Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Ricerche Spa filed Critical Menarini Ricerche Spa
Publication of AR020927A1 publication Critical patent/AR020927A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4727Mucins, e.g. human intestinal mucin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/0005Vertebrate antigens
    • A61K39/0011Cancer antigens
    • A61K39/001136Cytokines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/51Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Oncology (AREA)
  • Mycology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ARP990105316A 1998-10-30 1999-10-21 Composicion farmaceutica que contiene fragmentos de adn codificador de una proteina antigenica dotada de efecto antitumoral AR020927A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT1998MI002330A IT1303683B1 (it) 1998-10-30 1998-10-30 Composizione farmaceutiche ad azione antitumorale contenente dnacodificante per frammenti di una proteina antigenica.

Publications (1)

Publication Number Publication Date
AR020927A1 true AR020927A1 (es) 2002-06-05

Family

ID=11380969

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP990105316A AR020927A1 (es) 1998-10-30 1999-10-21 Composicion farmaceutica que contiene fragmentos de adn codificador de una proteina antigenica dotada de efecto antitumoral

Country Status (19)

Country Link
EP (1) EP1124956A2 (ja)
JP (1) JP2002528519A (ja)
CN (1) CN1324406A (ja)
AR (1) AR020927A1 (ja)
AU (1) AU1152200A (ja)
BG (1) BG105458A (ja)
BR (1) BR9914892A (ja)
CA (1) CA2348745A1 (ja)
CO (1) CO5231134A1 (ja)
CZ (1) CZ20011521A3 (ja)
EA (1) EA200100395A1 (ja)
HU (1) HUP0103784A2 (ja)
IT (1) IT1303683B1 (ja)
MX (1) MXPA01004186A (ja)
PE (1) PE20001287A1 (ja)
PL (1) PL348156A1 (ja)
SK (1) SK5712001A3 (ja)
TR (1) TR200101141T2 (ja)
WO (1) WO2000025827A2 (ja)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6548643B1 (en) 1994-11-16 2003-04-15 Austin Research Institute Antigen carbohydrate compounds and their use in immunotherapy
JP2003533181A (ja) * 2000-02-01 2003-11-11 ジ・オースティン・リサーチ・インスティテュート ムチン−1誘導抗原および免疫療法におけるその使用
WO2002022685A2 (en) * 2000-09-11 2002-03-21 Kufe Donald W Muc1 extracellular domain and cancer treatment compositions and methods derived therefrom
US20020110841A1 (en) 2000-12-22 2002-08-15 KUFE Donald W. Regulation of cell growth by MUC1
BRPI0408774A (pt) * 2003-03-24 2006-03-28 Scripps Research Inst vacinas de dna contra crescimento tumoral e seus usos
US7696306B2 (en) 2003-07-11 2010-04-13 Board of Agents of the University of Nebraska Compositions and methods for preventing or treating cancer
US8129506B2 (en) 2003-10-24 2012-03-06 Genzyme Corporation Modulation of the interaction of MUC1 with MUC1 ligands
US7871784B2 (en) 2007-02-02 2011-01-18 Dana-Farber Cancer Institute, Inc. Methods and compositions relating to the regulation of apoptosis by MUC1 and BH3-containing proapoptotic proteins
US7972870B2 (en) 2007-02-02 2011-07-05 Dana-Farber Cancer Institute, Inc. Methods and compositions relating to the regulation of MUC1 by HSF1 and STAT3
CN106279435B (zh) * 2016-08-16 2019-06-07 新乡医学院 靶向VEGF与mucin1的抗肿瘤疫苗、编码基因、表达载体、表达工程菌及应用
CN113321724B (zh) * 2021-03-24 2022-02-01 深圳市新靶向生物科技有限公司 一种与食道癌驱动基因突变相关的抗原肽及其应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1262545B (it) * 1993-10-25 1996-07-02 Menarini Ricerche Sud S P A A Sistema di espressione per linee cellulari eucariotiche
EP1012276A2 (en) * 1997-02-24 2000-06-28 Therion Biologics Corporation Recombinant pox virus for immunization against muc1 tumor-associated antigen

Also Published As

Publication number Publication date
MXPA01004186A (es) 2002-06-04
PE20001287A1 (es) 2000-12-07
EA200100395A1 (ru) 2001-10-22
PL348156A1 (en) 2002-05-06
ITMI982330A1 (it) 2000-04-30
CZ20011521A3 (cs) 2001-10-17
IT1303683B1 (it) 2001-02-23
JP2002528519A (ja) 2002-09-03
CO5231134A1 (es) 2002-12-27
SK5712001A3 (en) 2002-04-04
ITMI982330A0 (it) 1998-10-30
BR9914892A (pt) 2001-07-17
EP1124956A2 (en) 2001-08-22
HUP0103784A2 (hu) 2002-02-28
BG105458A (en) 2002-06-28
CA2348745A1 (en) 2000-05-11
TR200101141T2 (tr) 2001-09-21
WO2000025827A2 (en) 2000-05-11
CN1324406A (zh) 2001-11-28
WO2000025827A3 (en) 2000-08-10
AU1152200A (en) 2000-05-22

Similar Documents

Publication Publication Date Title
AR020927A1 (es) Composicion farmaceutica que contiene fragmentos de adn codificador de una proteina antigenica dotada de efecto antitumoral
BR0109346A (pt) Combinações de substâncias ativas com propriedades inseticidas e acaricidas
ATE544776T1 (de) Chimäre dna-bindeproteine
ECSP024352A (es) Nueva composicion farmaceutica
AR020048A1 (es) Un polipeptido dependiente de la vitamina k, una composicion farmaceutica que lo comprende, el uso del mismo para la manufactura de un medicamento, unacido nucleico aislado que codifica a dicho polipeptido y una celula hospedante de mamifero.
BG66080B1 (bg) Заместени тиоацетамиди
CY1117746T1 (el) Αντιγονα αιμοφιλου της γριπης και αντιστοιχα θραυσματα dna
CY1105555T1 (el) Ανθρωπινα πολυπεπτιδια pellino
DE69329195D1 (de) Rekombinante dna moleküle die aminopeptidase enzyme kodieren und ihre anwendung für die herstellung von impfstoffen gegen helminth infektionen
BR0209109A (pt) Método para fabricação de uma restauração dental
DE69533359D1 (de) Veränderte menschliche c3-proteine
NO20052216L (no) Smertestillende midler
ATE410514T1 (de) Calciumbindende rekombinante antikörper gegen protein c
DE69515340T2 (de) Impfstoff gegen mycobakterielle infektionen
AR002742A1 (es) Proteina reguladora del tipo adiposo, procedimiento para producir dicha proteina, formulaciones farmaceuticas que la incluyen, molecula de adn aisladaque codifica dicha proteina, vector y celulas recombinantes que comprenden dicho adn
NO20014537D0 (no) AKT-nukleinsyrer, -polypeptider og anvendelse av disse
BR0208740A (pt) Sistema de camada termoabsorvente
DK1219301T3 (da) Vacciner, som indeholder hybridpolypeptider, der består af mindst to forskellige allergene proteiner
AR027694A1 (es) Uso de la proteina mia para el tratamiento de enfermedades autoinmunes
ES2013321A6 (es) Un metodo de produccion de anticuerpos monoclonales
DE50212580D1 (de) Rekombinantes mva mit der fähigkeit zur expression von hcv struktur-antigenen
AU2003260452A8 (en) Use of granzyme b as an hsp70/hsp70 peptide dependent inducer of apoptosis in tumor cells
ES2067501T3 (es) Antigeno recombinante de treponema hyodysenteriae y sus usos.
DK610488A (da) Antikoagulatorisk protein pp4-x, dets fremstilling og anvendelse
BR0214288A (pt) Anticorpos monoclonais especìficos para tumor, ácidos nucléicos que codificam tais anticorpos e método para redução de proliferação de células neoplásicas